References
- http://www.wcvb.com/health/superfoods-showing-promise-as-effective-treatments-for-chronic-disease/26004284#!NYMvj
- http://en.wikipedia.org/wiki/Lunasin. Accessed August 10, 2014.
- Hernandex-Ledesma B, Hsieh C, de Lumen B.Lunasin, a novel seed peptide for cancer prevention. Peptides. 2009;30:426–30.
- Liu J, Jia S, Kirberger M, Chen N.Lunasin as a promising health-beneficial peptide. Eur Rev Med Pharmacol Sci. 2014;18:2070–5.
- Hernandez-Ledesma B, Hsieh CC, de Lumen B.Antioxidant and anti-inflammatory properties of cancer preventive peptide lunasin in RAW 264.7 macrophages. Biochem Biophys Res Commun. 2009;390:803–8.
- http://www.ncbi.nlm.nih.gov/ pubmed search lunasin (all fields) AND clinical trial [ptyp]. Accessed August 20, 2014.
- http://www.clinicaltrials.gov/ct2/results?term = lunasin. Accessed August 20, 2014.
- http://filgenbio.com/about/. Accessed August 20, 2014.
- Henkel JS, Engelhardt J, Siklos L, Simpson E, Kim S, Pan T, et al.Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann Neurol. 2004;55:221–35.
- Brettschneider J, Toledo J, van Deerlin V, Elman L, McClusley L, Lee V, Trojanowski J.Microglial activation correlates with disease progression and upper motor neuron clinical symptoms in patients with amyotrophic lateral sclerosis. PLoS One. 2013 2;7:e39216.
- Parakh S, Spencer D, Halloran M, Soo K, Atkin J. Redox regulation in amyotrophic lateral sclerosis. Ox Med Cell Longev. 2013;2013:408681.
- Miller R, Block G, Gopalakrishnan V, McGrath M, Study Group NP001. Phase II safety of NP001: a novel immune regulator for ALS. Amyotroph Lateral Scler. 2012;13:28.
- www.clinicaltrials.gov/ct2/show/NCT01786174?term = fingolimod+ a;s&rank = 1. Accessed August 11, 2014.
- Orrell R, Lane R, Ross M.A systematic review of anti- oxidant treatment for amyotrophic lateral sclerosis/motor neuron disease. Amyotroph Lateral Scler. 2008;9:195–211.
- DeMejia E, Dia V. Lunasin and lunasin-like peptides inhibit inflammation through suppression of NF-kappaB pathway in the macrophage. Peptides. 2009;30:2388–98.
- Rentzos M, Rombos A, Nikolaou C, Zoga M, Zouvelou V, Dimitrakopoulos A, et al.Interleukin-15 and interleukin-12 are elevated in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Eur Neurol. 2010;63:285–90.
- Kuhle J, Lindberg L, Regeniter A, Mehling M, Steck A, Kappos L, et al.Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis. Eur J Neurol. 2009;16:771–4.
- Mitchel R, Freeman W, Randazzo W, Stephens H, Beard J,* et al. A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis. Neurology. 2009;72:14–9.
- Cereda C, Baiocchi C, Bongioanni P, Cova E, Guareschi S, Metilli M, et al.TNF and sTMFR1/2 plasma levels in ALS patients. J Immunol. 2008;194:123–31.
- Poloni M, Facchetti D, Mai R, Michelli A, Agnoletti L, Francolini G, et al.Circulating levels of tumour necrosis factor-α and its soluble receptors are increased in the blood of patients with amyotrophic lateral sclerosis. Neurosci Lett. 2000;287:211–4.
- Cudkowicz M, Shefner J, Schoenfeld D, Zhang H, Andreasson K, Rothstein J, et al.Trial of celecoxib in amyotrophic lateral sclerosis. Ann Neurol. 2006;60:22–31.
- Hermandez-Ledesma B, Hsieh CC, DeLumen BO.Relationship between lunasin's sequence and its inhibitory activity of histones H3 and H4 acetylation. Mol Nutr Food Res. 2011;55:989–98.
- Pabona J, Dave B, Su Y, Montales M, deLumen B, deMejia E, et al. The soybean peptide lunasin promotes apoptosis of mammary epithelial cells via induction of tumor suppressor PTEN: similarities and distinct actions from soy isoflavone genistein. Genes Nutr. 2103;8:78–90.
- Cudkowicz M, Andres P, Macdonald S, Bedlack R, Choudry R, Brown R, et al.Phase II study of sodium phenylbutyrate in ALS. Amyotroph Lateral Scler. 2009;10: 99–106.
- Malaspina A, Kaushik N, deBelleroche J. Differential expression of 14 genes in amyotrophic lateral sclerosis spinal cord detected using gridded cDNA arrays. J Neurochem. 2001;77:132–45.
- Dangond F, Hwang D, Camelo S, Pasinelli P, Frosch MP, Stephanopoulos G, et al.Microarray analysis shows distinct changes in the molecular signature of gene expression in both ALS animal models and patients. Physiol Genomics. 2004;16:229–39.
- Lee J, Ryu H, Yoon Y, Kowall N, Ryu H. Therapeutic targeting of epigenetic components in amyotrophic lateral sclerosis. Curr Med Chem 2014;21:3576–82.
- http://reliv.com/lunarich-products. Accessed August 10, 2014.
- Rowland L.Progressive muscular atrophy and other lower motor neuron syndromes of adults. Muscle Nerve. 2010; 41:161–5.
- Ince P, Evans J, Knopp M, Forster G, Hamdalla HH, Wharton SB, et al.Corticospinal tract dysfunction in the progressive muscular atrophy variant of ALS. Neurology. 2003;60:1252.
- Kim W, Liu X, Sandner J, Pasmantier M, Andrews J, Rowland L, et al.Study of 962 patients indicates progressive muscular atrophy is a form of ALS. Neurology. 2009; 73:1686.
- Visser J, van den Berg-Vos M, Franssen H, van den Berg L, Vogels J, Wokke J, et al.Mimic syndromes in cases of progressive spinal muscular atrophy. Neurology. 2002;58:1593–6.
- Petrou P, Argov A, Lennon V, Gotkins M, Kassis I, Vaknin-Dembinsky A, et al. Rare combination of myasthenia and motor neuronopathy, responsive to MSC-NTF stem cell therapy. Muscle Nerve. 2014;49:455–7.
- http://www.medterms.com/script/main/art.asp?articlekey= 31481. Accessed August 23, 2014.
- http://en.wikipedia.org/wiki/Reporting_bias. Accessed August 23, 2014.
- http://www.patientslikeme.com/treatments/show/26756-lunasin-side-effects-and-efficacy#overview. Accessed August 10, 2014.
- Dzirkale Z, Rumaks J, Svirskis S, Mazina O, Allikat A, Rinken A, et al. Lunasin-induced behavioral effects in mice: focus on the dopaminergic system. Behav Brain Res. 2013;256:5–9.
- http://reliv.com/compplan. Accessed August 23, 2014.
- http://reliv.com/p/24k. Accessed August 23, 2014.
- http://reliv.com/p/arthaffect. Accessed August 23, 2014.
- http://reliv.com/p/innergize. Accessed August 23, 2014.
- http://reliv.com/reliv-luna-rich-soy-powder-bioavailability. Accessed August 23, 2014.
- http://relivwatchdog.blogspot.com/search?updated-min = 2014-01-01T00:00:00-08:00&updated-max = 2015-01-01T00:00:00-08:00&max-results = 6. Accessed August 23, 2014.
- https://www.consumerlab.com/answers/What+ is+ lunasin+ and+ does+ it+ really+ reduce+ cholesterol%3F/lunasin_cholesterol/. Accessed August 24, 2014.
- http://www.lunasin.com/FAQ.aspx. Accessed August 24, 2104.
- Personal email from Eileen Bendiksen Rph, who works with Reliv; accessed June 3, 2014.